Lymphoproliferative Disorders

"Lymphoproliferative Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Disorders characterized by proliferation of lymphoid tissue, general or unspecified.

Descriptor ID	D008232
MeSH Number(s)	C15.604.515 C20.683.515
Concept/Terms	Lymphoproliferative Disorders Lymphoproliferative Disorders Disorder, Lymphoproliferative Disorders, Lymphoproliferative Lymphoproliferative Disorder X-Linked Lymphoproliferative Disorder X-Linked Lymphoproliferative Disorder Disorder, X-Linked Lymphoproliferative Disorders, X-Linked Lymphoproliferative Lymphoproliferative Disorder, X-Linked Lymphoproliferative Disorders, X-Linked X Linked Lymphoproliferative Disorder X-Linked Lymphoproliferative Disorders Epstein-Barr Virus Infection, Familial Fatal Epstein Barr Virus Infection, Familial Fatal Epstein-Barr Virus-Induced Lymphoproliferative Disease In Males Epstein Barr Virus Induced Lymphoproliferative Disease In Males Familial Fatal Epstein-Barr Infection Familial Fatal Epstein Barr Infection Immunodeficiency 5 Immunodeficiency 5s Duncan's Syndrome Lymphoproliferative Disease, X-Linked Disease, X-Linked Lymphoproliferative Diseases, X-Linked Lymphoproliferative Lymphoproliferative Disease, X Linked Lymphoproliferative Diseases, X-Linked X-Linked Lymphoproliferative Diseases Lymphoproliferative Syndrome, X-Linked, 1 Purtilo Syndrome Purtilo Syndromes Syndrome, Purtilo Syndromes, Purtilo X-Linked Lymphoproliferative Disease X Linked Lymphoproliferative Disease X-Linked Lymphoproliferative Syndrome Lymphoproliferative Syndrome, X-Linked Lymphoproliferative Syndromes, X-Linked Syndrome, X-Linked Lymphoproliferative Syndromes, X-Linked Lymphoproliferative X Linked Lymphoproliferative Syndrome X-Linked Lymphoproliferative Syndromes Duncan Disease Disease, Duncan Immunodeficiency, X-Linked Progressive Combined Variable Immunodeficiency, X Linked Progressive Combined Variable

Below are MeSH descriptors whose meaning is more general than "Lymphoproliferative Disorders".

Diseases [C]
Hemic and Lymphatic Diseases [C15]
Lymphatic Diseases [C15.604]
Lymphoproliferative Disorders [C15.604.515]
Immune System Diseases [C20]
Immunoproliferative Disorders [C20.683]
Lymphoproliferative Disorders [C20.683.515]

Below are MeSH descriptors whose meaning is related to "Lymphoproliferative Disorders".

Below are MeSH descriptors whose meaning is more specific than "Lymphoproliferative Disorders".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Lymphoproliferative Disorders" by people in this website by year, and whether "Lymphoproliferative Disorders" was a major or minor topic of these publications.

Bar chart showing 40 publications over 23 distinct years, with a maximum of 3 publications in 2002 and 2005 and 2006 and 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	1	1	2
1996	2	0	2
1997	2	0	2
1998	1	1	2
2002	2	1	3
2003	1	0	1
2004	1	0	1
2005	3	0	3
2006	2	1	3
2009	0	1	1
2010	1	1	2
2011	1	0	1
2012	2	0	2
2013	1	0	1
2014	1	0	1
2015	1	0	1
2016	0	1	1
2018	1	0	1
2019	2	1	3
2021	2	0	2
2022	2	0	2
2023	2	0	2
2024	1	0	1

Below are the most recent publications written about "Lymphoproliferative Disorders" by people in Profiles.

Hrizat AS, Gong J, Gargano SM. Institutional Experience of Lymphoproliferative Disorders with Initial Diagnosis Made via Fine Needle Aspiration at Otolaryngology Clinic. Acta Med Acad. 2024 Dec; 53(3):274-285.

View in: PubMed
Amengual JE, Pro B. How I treat posttransplant lymphoproliferative disorder. Blood. 2023 10 26; 142(17):1426-1437.

View in: PubMed
Sherazi S, Schleede S, McNitt S, Casulo C, Moore JE, Storozynsky E, Patel A, Vidula N, Aktas MK, Zent CS, Goldenberg I. Arrhythmogenic Cardiotoxicity Associated With Contemporary Treatments of Lymphoproliferative Disorders. J Am Heart Assoc. 2023 03 21; 12(6):e025786.

View in: PubMed
Mitsuhashi S, Chalikonda D, Nazir B, Agarwal A, Coben R. Recurrent bleeding duodenal and colonic ulcers due to post-transplant lymphoproliferative disorder. Clin J Gastroenterol. 2023 Feb; 16(1):39-42.

View in: PubMed
Seshadri M, Crane GM, Gergis U. Ofatumumab for Post-Transplant Lymphoproliferative Disorder. Hematol Oncol Stem Cell Ther. 2022 Mar 01; 15(1):68-73.

View in: PubMed
Hong J, Johnson WT, Kartan S, Gonsalves AS, Fenkel JM, Gong JZ, Porcu P. Durable Response to Brentuximab Vedotin Plus Cyclophosphamide, Doxorubicin, and Prednisone (BV-CHP) in a Patient with CD30-Positive PTCL Arising as a Post-Transplant Lymphoproliferative Disorder (PTLD). Curr Oncol. 2021 12 02; 28(6):5067-5072.

View in: PubMed
Pearse WB, Petrich AM, Gordon LI, Karmali R, Winter JN, Ma S, Kaplan JB, Behdad A, Klein A, Jovanovic B, Helenowski I, Smith SM, Evens AM, Pro B. A phase I/II trial of brentuximab vedotin plus rituximab as frontline therapy for patients with immunosuppression-associated CD30+ and/or EBV?+?lymphomas. Leuk Lymphoma. 2021 12; 62(14):3493-3500.

View in: PubMed
Youssefian L, Vahidnezhad H, Yousefi M, Saeidian AH, Azizpour A, Touati A, Nikbakht N, Hesari KK, Adib-Sereshki MM, Zeinali S, Mansoori B, Jazayeri A, Karamzadeh R, Fortina P, Jouanguy E, Casanova JL, Uitto J. Inherited Interleukin 2-Inducible T-Cell (ITK) Kinase Deficiency in Siblings With Epidermodysplasia Verruciformis and Hodgkin Lymphoma. Clin Infect Dis. 2019 05 17; 68(11):1938-1941.

View in: PubMed
Van Besien K, Bachier-Rodriguez L, Satlin M, Brown MA, Gergis U, Guarneri D, Hsu J, Phillips AA, Mayer SA, Singh AD, Soave R, Rossi A, Small CB, Walsh TJ, Rennert H, Shore TB. Prophylactic rituximab prevents EBV PTLD in haplo-cord transplant recipients at high risk. Leuk Lymphoma. 2019 07; 60(7):1693-1696.

View in: PubMed
Kartan S, Johnson WT, Sokol K, Alpdogan O, Gru AA, Nikbakht N, Porcu P. The spectrum of CD30+ T cell lymphoproliferative disorders in the skin. Chin Clin Oncol. 2019 Feb; 8(1):3.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement